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Abstract 
 
A comprehensive and standardized system to report lipid structures analyzed by mass spectrometry is es-
sential for the communication and storage of lipidomics data. Herein, an update on both the LIPID MAPS 
classification system and shorthand notation of lipid structures is presented for lipid categories Fatty Acyls 
(FA), Glycerolipids (GL), Glycerophospholipids (GP), Sphingolipids (SP), and Sterols (ST). With its major 
changes, i.e. annotation of ring double bond equivalents and number of oxygens, the updated shorthand 
notation facilitates reporting of newly delineated oxygenated lipid species as well. For standardized report-
ing in lipidomics, the hierarchical architecture of shorthand notation reflects the diverse structural resolution 
powers provided by mass spectrometric assays. Moreover, shorthand notation is expanded beyond mamma-
lian phyla to lipids from plant and yeast phyla. Finally, annotation of atoms is included for the use of stable 
isotope-labelled compounds in metabolic labelling experiments or as internal standards. 
 
This update on lipid classification, nomenclature and shorthand annotation for lipid mass spectra is consid-
ered a standard for lipid data presentation. 
 
Keywords: mass spectrometry; lipidomics; nomenclature; shorthand notation, fatty acyls; glycerolipids; 
glycerophospholipids; sphingolipids; sterols. 
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1. Introduction 
 
Lipids have become increasingly recognized as the central metabolites affecting human physiology and 
pathophysiology and LIPID MAPS has recently expanded its tools, resources, data, and training as a free 
resource dedicated to serving the lipid research community (1). Following development of the LIPID MAPS 
nomenclature, classification and structural representation system (2, 3), an initial shorthand nomenclature 
was proposed (4), which included a structural hierarchy as shown by others as well (5, 6). These were the 
first attempts to provide rules for reporting mass-spectrometric data dependent on the power for structural 
resolution of lipids by the instrumental set-ups in use at that time.  
 
Today, we recognize that the field has evolved in often diverging ways and that this has not enabled a 
unifying naming convention to be adopted throughout. For example, alternative shorthand notation has 
evolved for some lipid classes, a plethora of newly determined structures for lipids from various classes and 
phylogenetic kingdoms (higher plants and yeasts) have been described, and progress in the technological 
development of mass spectrometers with greater structural resolution as well as advances in automation in 
interpreting high-throughput data has occurred. To address this, it is the aim of this report to take into ac-
count these developments and to present an update on the LIPID MAPS classification and a pragmatic 
highly usable shorthand notation for those active in lipid research. This update will focus on five of the eight 
LIPID MAPS categories (2), namely Fatty Acyls (FA), Glycerolipids (GL), Glycerophospholipids (GP), 
Sphingolipids (SP), and Sterols (ST). Annotation is modified to permit annotation of oxygenated lipids and 
examples will be given for lipid classes occurring outside the mammalian kingdom.   
 
“Biological intelligence” has been considered as topical knowledge about a lipid molecule, such as its struc-
tural building blocks, enzymatic pathways for generation and metabolism, and biological functions (4). In-
terpretation by biological evidence in shorthand notation can be useful when mass spectra contain structural 
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ambiguities or lack of clear structural evidence. Consequently, annotations with the help of biological evi-
dence contain assumptions, and it must be recognized and recorded that this may lead to misinterpretations. 
Moreover, in the pragmatic approach presented in this paper, we will make more use of common and/or 
trivial names for the shorthand notation. For example, the structures of sterols, prostaglandins, resolvins, 
etc. have been characterized by chemical and spectroscopic methods, including stereochemistry, and com-
mon names exist, as do shorthand notations in many cases. Their mass spectra are also known; however, 
their stereochemistry and isomerism and other structural information often cannot be deduced directly from 
the spectra, when these lipids are measured in biological samples. Assignment of a common name or of 
shorthand notation to such chromatographic and MS/MS data is permissible, but it may be based on anno-
tation which includes biological intelligence, and that needs to be clearly stated as well.  
 
In any case, assumptions made should be striking a unique balance between what we think we know about 
structure and function of a lipid molecule and what a specific MS-based analytical method definitively in-
forms us about the lipid structure.  
 
 
2. Update on Nomenclature and Classification  
 
Modification of Fatty Acyls by oxygen, either catalyzed enzymatically or by means of radical chemistry, is 
an important focus in biomedical research, due to the impressive biological activities of products thus ob-
tained. Based on these two mechanisms, all compounds originating from polyunsaturated fatty acyls 
(PUFA) having methylene-interrupted cis-double bonds (also chemically referred to as allylic double bonds) 
and being enzymatically or non-enzymatically oxygenated are grouped within the appropriate class in the 
Fatty Acyl category. Historically, the term “eicosanoid” has included “related oxygenated polyunsaturated 
fatty acids” with shorter or longer chain lengths, but in the LIPID MAPS classification, compounds are 
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strictly assigned to a class based on their chain length (e.g. Octadecanoids, Eicosanoids, Docosanoids). Re-
cently, the common name “oxylipins”, standing for “oxygenated fatty acyls”, has come into widespread use.  
Similarly, in the Glycerophospholipids (GP) category, many newly described phospholipids contain oxy-
genated fatty acyls (or oxylipins) often termed “oxygenated phospholipids”. Those are produced by oxy-
genation of constituent fatty acyls enzymatically and non-enzymatically, or by chemical modification of 
polar head groups containing an amino function (PE and PS), i.e. N-modified phospholipids. 
 
In the following, we elaborate first on experimental prerequisites for correct annotation of lipid mass spec-
trometric data and, second, present the updates on rules for using shorthand notation. Finally, in order of 
categories, we present mostly in the form of easily readable tables, all updates on lipid nomenclature and 
classification including respective shorthand abbreviations according to the LIPID MAPS web resources 
and the updated shorthand notation for lipid species and lipid molecular species. To further enhance the 
understanding of shorthand notation, some chemical structures are presented in the tables. The updated 
shorthand notation schemes described herein have been incorporated into a number of key resources on the 
LIPID MAPS website, notably the LIPID MAPS Structure Database (LMSD) and the MS search tools (see 
4.1 below), by generating level-specific abbreviations (e.g. sum-composition and chain-specific annota-
tions) for lipid structures. This approach is important in terms of the development of MS search databases 
which are appropriate for the technique used (sum-composition databases for precursor ion data and chain-
composition databases for tandem MS data).   
 
 
3. Experimental prerequisites for correct annotation 
 
All lipid species and lipid molecular species data presented need information on levels of structural resolu-
tion attained by mass spectrometric analysis, and sufficient supplementary data to justify annotation by 
7 
shorthand notation. At minimum such data should contain measured intact m/z value, adduct ion used for 
identification, retention time (RT) when chromatography is applied, measured fragment m/z values. 
 
Assignment and therefore use of specific shorthand nomenclature for defined functional groups (Table 1) 
requires additional techniques. An example is derivatization of hydroxyl groups by trimethylsilylation fol-
lowed by GC/MS electron ionization (EI) and analysis of fragment ions formed. In many cases ESI-MS/MS 
of underivatized constituent fatty acyls in general leads to specific product ions, if ESI populates a charge 
site near the functional group (7). Definition of double bond positions can be determined by several tech-
niques including ozonolysis during analysis (OzID) (8), or specific adduct formation with acetone in pho-
tochemical Paterno-Büchi reaction (9). These reactions can be carried out in shotgun or LC-MS/MS exper-
iments. High energy MS/MS has been used to assign double bond position of fairly complex fatty acyls as 
well as methyl branching (10). Alternatively, GC/MS can be used including specific derivatization of the 
carboxylate group, to drive specific double bond fragmentation in EI spectra (11). Chemical ionization (CI) 
techniques are also useful by application of specific CI reagent gases to define double bond positions (12). 
 
Common names of lipid species, e.g. for certain fatty acids and for oxygenated fatty acids denote a chemi-
cally-defined structure including stereochemistry. For proper annotations in these cases, the analytical 
method has to provide for chiral separation of known stereoisomeric compounds. This validation demands 
data on reproducibility and limit of quantification. Similarly, when novel structures are described, analytical 
details proving structural details need to accompany the data. Guidelines for method validation and reporting 
of novel lipid molecules are currently being developed within the Lipidomics Standard Initiative (https://lip-
idomics-standards-initiative.org) as community-wide effort (13). 
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4. Updates on general rules for Shorthand Notation 
 
Here we describe updates and rules applicable to all lipid categories described below. This includes rules 
on the hierarchical concept and application of the nomenclature, annotation of lipid structures as well as on 
annotation of stable isotope-labelled lipids. Two major updates are: 
 The term “double bonds” (DB) is replaced by “double bond equivalents” (DBE), because removal 
of two hydrogen atoms from precursor lipid forms a double bond, an oxo group or a cyclic struc-
ture. Frequently, MS does not distinguish between these alternatives. 
 Oxygen atoms represent not only the main component introduced during oxygenation, but occurs 
also in hydroxy groups as a principal structural feature in many lipid classes such as sphingoid 
bases. Because hydroxy, oxo or other oxygen functional groups may not be differentiated by high 
resolution/accurate mass analysis, annotation is done by the number of oxygens linked to the hy-
drocarbon chain. 
 Use of parentheses and brackets is minimized. Parentheses indicate primarily positions and, with 
regard to functional groups only those with numbers behind them, like (OH)2, (NO2), (NH2). The 
use of square brackets is restricted to chemical configurations R and S, to stable isotopes, and to 
the frame of carbons in a ring structure. 
 
4.1. Hierarchical concept and application of Shorthand Notation 
 
 Upon application of a validated MS-method, interpretation of mass spectra by “biological intelli-
gence” and the use of common or trivial names, as alluded to specifically in the introduction, is 
permissible. Such annotations need to be clearly stated. Examples are ambiguities pertaining to 
bond type, oxygenated groups, branched chains. 
 “Species level” is now the lowest hierarchical level. It represents the sum composition, i.e., sum of 
carbon atoms, DBE and number of additional oxygen atoms, e.g. FA 18:1;O. It thus replaces former 
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“Lipid class level” mass (i.e. lipid class and the – uncharged - molecular mass). Of note, for sterols 
the ABCD ring system is assumed and not expressed as DBE.  
 “Phosphate-position level” annotates positions of phosphate group(s), e.g. PIP(3’) or PIP2(4’,5’) 
at phosphatidylinositolphosphate. 
 “Molecular species level” pertains to all categories addressed here and is reached as soon as con-
stituent fatty acyl/alkyl-residues are identified, e.g. TG 16:0_18:1_18:1, a triglyceride. 
 “sn-Position level” is a more refined level in GL and GP categories, enabling annotation of sn-
position of constituent fatty acyl/alkyl constituents at the glycerol backbone as indicated by a slash, 
e.g. TG 16:0/18:1/18:1.  
 “DB-position level” or “DBE-position level” pertain to species having constituents with defined 
position of double bonds or double bond equivalents, e.g. FA 18:2(9,11);O.  
  “Structure defined level” annotates molecular species composed of various constituents and func-
tional groups, yet without positions and stereochemical details, e.g. FA 18:2;OH. 
 “Full structure level” annotates molecular species composed of various constituents and functional 
groups including positions, yet without stereochemical details, e.g.  FA 18:2(9Z,11E);13OH. 
 “Complete structure level” defines detailed structures of all functional groups including stereo-
chemistry as shown in the LMSD, e.g. 13R-HODE, 13S-HODE (= common name). 
 See Table 1 for abbreviations of functional groups/side chains and conjugates pertaining to “Struc-
ture defined level” and onwards to higher levels. 
 
Figure 1 presents such hierarchical scheme, taking the example of glucosylceramide. 
 
A word of caution is appropriate here: Annotations based solely on m/z–features and on returns from data 
base retrieval are frequently incorrect due to over-interpretation of experimental data, i.e., returns of chem-
ically defined lipid molecules at Complete structure level (27). It is therefore of major importance that da-
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tabase search tools return appropriate annotations based on sum composition, i.e., at Species level and Mo-
lecular species level. Such tools are, for example, the LIPID MAPS MS search tools (https://lipid-
maps.org/resources/tools/bulk_structure_searches_overview.php) (see also comment in the discussion) or 
the “ALEX lipid calculator” (http://alex123.info/ALEX123/MS.php) (28). 
 
4.2. Annotation of lipid structures   
 
 Lipid species are annotated by class shorthand abbreviation (see Tables 2A-6A), followed by a 
space and C-atoms:DBE, e.g. TG 54:5, or C-atoms:DBE;O-atoms in fatty acyl/alkyl residues, e.g. 
FA 18:1;O or PC 38:3;O2.  
 Variable constituents like fatty acyls/alkyls are assigned based on their mass as number of C-atoms 
and number of DBE (C-atoms:DBE), when experimental proof for DB is provided the annotation 
is C-atoms:DB. Where applicable number of oxygen-atoms is added, separated by a semi-colon, 
e.g. C-atoms:DBE;O-atoms.  
 DB-position is indicated by a number according to Δ-nomenclature (geometry unknown), or a 
number followed by geometry (Z for cis, E for trans). Specific techniques are required for deter-
mination of DB-position (or geometry) to validly use this level of annotation, e.g. FA 18:2(9,12), 
FA 18:2(9Z,12Z). 
 Positions for all functional groups are stated in front of functional group abbreviation, e.g. FA 
20:4;12OH.  
 Generally, all functional groups (see Table 1A for abbreviations) are separated by a semicolon 
after the number of DBE. Functional groups are placed inside a separate pair of parentheses, 
only if more than one followed by the number of groups, e.g. FA 20:3;(OH)2;oxo. Moreover, func-
tional groups containing numbers such as NO2 or NH2 are generally placed inside a separate pair 
of parentheses, e.g. FA 18:1;(NO2). The order of functional groups follows the IUPAC hierarchy 
(14). 
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 Except for DBE/DB-position, proven positions of all other functional groups are stated according 
to Δ-nomenclature in front of the functional group abbreviation that are separated by a comma if 
more than one, e.g. FA 20:3(5Z,13E);11OH,15OH;9oxo 
 Cyclic structures cyX (X = number of ring atoms, see Table 1B for abbreviations) are presented in 
front of other functional groups. Their structural details are annotated within a pair of square brack-
ets. Within the square brackets the positions of ring atoms, separated by hyphen, are placed in front 
of the cyX annotation. Other functional groups are placed after the ring structure of the cyX anno-
tation, e.g. FA 20:2;[8-12cy5;11OH;9oxo];15OH = 8-iso-PGE2 or PGE2. 
 Carbohydrate structures (Table 1C), e.g. in complex glycosphingolipids are annotated as de-
scribed for glycans (https://www.ncbi.nlm.nih.gov/glycans) (15). When the sequence of sugars 
components is known they are shown in this order separated by a hyphen, e.g. Gal-Glc-Cer 
18:1;O2/16:0. In case the sequence is unknown the components (followed by their number if 
more than one) are shown in alphabetic order in front of the respective lipid backbone, e.g. 
Gal2GlcCer 18:1;O2/16:0. 
 Acyl-linkages (N- and/or O-) are annotated by FA C-atoms:DBE inside a separate pair of paren-
theses with proven position in front, e.g. Cer 18:1;O2/26:0;26O(FA 18:2). 
 Alkyl-linkages (N- and/or O-) are annotated by C-atoms:DBE inside a separate pair of parentheses 
with proven position in front, e.g. FA 18:1(12Z);9O(16:1) for an ether lipid. 
 When functional groups are part of lipid class abbreviation, e.g. PIP2 or SPBP, their proven posi-
tions are shown inside parentheses, separated by a comma if more than one, e.g. PIP2(4’,5’) 38:4 
or SPBP(1) 18:1;O2. 
 Greek letters are transcribed to Latin letters as follows: α to a, β to b, γ to g, δ to d, ω to w.  
 Proven stereochemistry is shown after the respective functional group/side chain in square brackets 
[R] or [S], e.g. FA 20:4(6Z,8E,10E,14Z);5OH[S],12OH[R] = LTB4. 
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4.3. Annotation of isotope-labelled lipids 
 
 Isotope containing lipid structures are indicated in square brackets annotating the isotope, followed 
by the number of isotopic atoms, e.g. FA 18:1[13C5].  
 Multiple isotopes are separated by a comma, e.g. FA 18:1[13C5,D4].  
 When positions of isotopes are known, they are indicated in a separate pair of parentheses in front 
of the isotope number, e.g. FA 18:1[(14,15,16,17,18)13C5].  
 Isotopes in fatty acyls or alkyls and in sphingoid bases are indicated in square brackets after the 
number of DBE, e.g. PC 34:1[D9] or PC O-16:0_18:1[13C5] and in Cer 34:1;O2[13C3], respec-
tively. Isotopes in head groups of these structures are indicated in square brackets after class short-
hand abbreviation, e.g. PC[D9] 34:1, TG[13C3] 54:3, SM[D9] 34:1;O2. 
 When positions of isotopes in the lipid are not known, they are indicated in square brackets in front 
of class shorthand abbreviation, e.g. [D5]PC 34:1, [13C7]TG54:3. 
 
 
5. Fatty Acyls (FA) 
 
5.1. Fatty Acyls  
 
Shorthand abbreviations for Fatty Acyl classes are stated in Table 2A. 
  
Table 2B shows that lowest resolution level is based on m/z values, i.e., annotation at Species level (low 
mass resolution mass spectrometry, e.g. carboxylate anion, and oxygen atoms from functional groups). In 
addition, it is assumed that only a straight-chain fatty acid with or without DBE(s) is present. High mass 
resolution with accurate mass measurements may identify additional elements such as oxygen atoms of 
functional groups. Thus, a limited amount of structural information is provided at this level of analysis 
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following the rules alluded to in Section 4.2., i.e. Species level. Annotation at DB-position level requires 
techniques such as ozonolysis (8) or photochemical derivatization (9) or GC-MS. The use of trivial or com-
mon names for even simple fatty acids implies additional methods have been used to define the exact struc-
ture such as a straight-chain, positions of double bonds, or double bond geometries. Chiral chromatography 
preceding MS/MS is required for respective stereochemistry. Since this is generally not routinely done, 
investigators should note in their reports when using a common name for a fatty acid that “The identity and 
stereochemistry of the fatty acid species reported using a common name (e.g., oleic acid, linolenic acid, 
arachidonic acid, etc.) is assumed based on biological intelligence”. This comment applies to simple as well 
as complex lipids that include fatty acids as part of the structure (e.g., glycerophospholipids, triacylglycerols, 
etc.). Examples for shorthand notation of fatty acids are presented in Table 2B.  
 
Fatty acyl esters, i.e. wax esters (WE), wax diesters (WD), Fatty acyl estolides (FAHFA, FA-EST), as well 
as N-acyl amines (NA) and N-acyl ethanolamines (NAE) are shown in Table 2C. 
 
5.2. Oxygenated Fatty Acyls  
 
Lipidomic studies of “oxygenated fatty acyls”, commonly referred to as “oxylipins” or “oxygenated 
PUFAs” in the literature, involves analysis of enzymatically and non-enzymatically generated lipids such 
as octadecanoids, eicosanoids, docosanoids, do- and tetratriacontanoids (Table 2D, E, F). Enzymatically-
generated isomers include prostaglandins, leukotrienes, and the various “specialized pro-resolving media-
tors” (SPMs), i.e., lipoxins, protectins, maresins, and resolvin D/Es (Table 2F) (16). Non-enzymatic oxy-
genation of polyunsaturated fatty acids leads to numerous cyclic structures with various stereochemistry, 
such as phytoprostanes, isoprostanes, neuroprostanes, and all families of furans. Some of these isopros-
tanoids were identified over 25 years ago, particularly those of mammalian origin (17) and more recently 
also as components in foods of plant origin (18). The nomenclature for isoprostanoids is based on Taber et 
al. (19) and Rokach et al. (20), an update appeared in 2010 (21). Table 2G presents the precursor-product 
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relationships for the classes of phytoprostanes, isoprostanes, and neuroprostanes, for which abbreviations 
PhytoP, IsoP, and NeuroP, respectively, have been proposed. 
 
Standards for structural validation by MS-inspection of these oxygenated fatty acids are described by Galano 
et al. (17) and are in agreement with those referred to for oxylipins (22). Specific shorthand nomenclature 
has been previously suggested and widely used for polyunsaturated, oxygenated fatty acids (23). 
 
The use of a common name (Tables 2B, E, D) for fatty acyls, or in reporting lipidomic studies also requires 
a high level of validation typically with a representative biological sample using for example stable isotope 
dilution and chiral LC-MS/MS or capillary GC/MS with highly reproducible retention times for authentic 
standards. Otherwise, assumptions made on the basis of biological intelligence must be clearly stated.  
 
 
6. Glycerolipids (GL)  
 
See Table 3A, B for class abbreviations and examples, respectively. Lipid class abbreviation followed by 
number of C-atoms:number of DBE, for oxygenated lipids C-atoms:DBE;O-atoms, are as described in Sec-
tion 4.2.  
 
Glycerolipids with known fatty acyl/alkyl constituents (molecular species): 
 separator _: sn-position of acyl/alkyl constituents is not known. Constituents are presented in the 
order of increasing number of C-atoms, as are DB (DBE)-numbers for each C-atom number, e.g. 
TG 16:0_18:1_18:3. 
 separator /: sn-position of acyl/alkyl constituents is proven (order sn-1/sn-2/sn-3; no FA linked 
0:0), e.g. TG 16:0/18:3/18:1. 
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 When only one acyl chain of TG is known, it is presented in front of the sum of the remaining two 
acyl residues, e.g. TG 16:0_36:3. 
 When only one of the sn-positions is defined, this is indicated inside a pair of parentheses, e.g. TG 
16:0_18:1(sn-2)_18:0. 
Other bond types than ester bonds are indicated as follows in front of the sum of C-atoms for acyl/alkyl 
constituents:  
 O = alkyl, e.g. TG O-52:3 
 P = proven O-alk-1-enyl-bond (acid-sensitive ether bond in “neutral plasmalogens” is not counted 
as a DB/DBE within the acyl-chain), e.g. TG P-52:3 or at higher resolution TG P-16:0/18:3/18:1. 
 More than one "non"-ester bond is indicated in front of the bond type as d for di, t for tri, and e for 
tetra.  
 
 
7. Glycerophospholipids (GP) 
 
See Tables 4A, B, C for abbreviations and examples. Shorthand notation for phospholipid species contains 
abbreviation for phospholipid classes, followed by number of C-atoms:number of DBE, i.e. PS 36:4, for 
oxygenated lipids C-atoms:DBE;O-atoms, i.e. PS 36:3;O, as described in Section 4.2.  
 
7.1. Phospholipids (PL) and Lysophospholipids (LPL) 
 
Molecular species of phospholipids with known fatty acyl/alkyl constituents (Table 4B):  
 separator _: sn-position of acyl/alkyl constituents is not known. Order of constituent presentation 
as described for glycerolipids, e.g. PC 16:0_18:2. 
 separator /: sn-position of acyl/alkyl constituents is proven (sn-1/sn-2 or sn-2/sn-3); no constituent 
0:0; e.g. PC 16:0/18:2. 
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 For BMP and CL classes sn-position order will be sn-2/sn-3/sn-2'/sn-3' and sn-1/sn-2/sn-1'/sn-2', 
respectively. 
 When only one acyl chain or DG moieties of CL are known, sum of acyl residues are presented, 
e.g. CL 16:0_54:3 and CL 34:1_36:2, respectively. 
Lysophospholipid classes are abbreviated as stated in LIPID MAPS nomenclature (Table 4A). Molecular 
species with unknown sn-position are presented as, e.g. LPE 18:1, with known sn-position as LPE 18:1/0:0 
(Table 4B). 
 
Other bond types than ester bonds are indicated as described in Section 6 for Glycerolipids, e.g. for an ether 
phospholipid PE O-18:0/18:2, for a “plasmalogen” PE P-18:0/20:4. 
 
7.2. Phosphatidylinositol phosphates (PIPs) 
 
It is described in Section 4.2, when functional groups are part of lipid class abbreviation, their proven posi-
tions are shown directly at the abbreviation’s end inside parentheses, separated by a comma if more than 
one. A prominent example is PIP3(3’,4’,5’). Table 4C shows that “Phosphate position level” identifies 
phosphate position at inositol ring, i.e. PIP(3’) 38:4, otherwise it would be PIP 38:4. For ease of handling 
by databases, numbers of phosphates are not written in lower case. 
 
7.3. N-modified Phospholipids and Lysophospholipids 
 
The amino function in phosphatidylserines and phosphatidylethanolamines including their lysoforms is 
prone to react with a variety of electrophiles as has been shown in recent years (24). The products are 
generally termed N-mod PL and N-mod LPL in abbreviated form, common names and respective abbrevi-
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ations are shown in Table 4A. Structures at Species -, Molecular species -, and sn-Position levels are pre-
sented in shorthand notation as described in Sections 4.2 and in Section 6 for Glycerophospholipids, specific 
examples are shown in Table 4D. 
 
7.4. Oxygenated Phospholipids  
 
Phospholipids containing PUFA-constituents having methylene-interrupted cis-double bonds (allylic dou-
ble bonds) and/or polar headgroups having amino-residues are susceptible to oxidation with formation of 
‘Oxygenated Phospholipids’ (OxPL). OxPL so far is a general term for a class of lipids produced by several 
processes that most often cannot be distinguished by MS analysis of the products. In all these cases products 
are called OxPL (25). 
 
Respective modes for production are the following: 
 Oxygenation of PL to produce OxPL by direct action of lipoxygenases on PUFA constituents of PL 
gives rise to enzymatically produced specific oxPL. The stereochemistry of the resulting PUFA 
component usually reflects the specificity of the specific enzyme involved (26). 
 The Land’s cycle is an alternative mechanism for enzymatic OxPL formation. Free, unesterified 
PUFAs liberated by phospholipase A2 and other enzymatic pathways from PL are first oxygenated 
by lipoxygenases, cyclooxygenases or CYP450 oxygenases. Resulting oxygenated PUFAs can be 
then re-esterified into PLs resulting in the indirect enzymatic formation of specific oxPL.  
 Non-enzymatic reactions are induced by free-radical oxygen/nitrogen species reacting directly with 
the PUFA constituents of PL or with free PUFAs which become incorporated into the PL by acyl 
transferases producing non-enzymatically derived oxPL. This oxygen transfer to PUFAs can further 
lead to DB rearrangement, cyclization and even truncation of such acyl-chains resulting in complex 
mixtures of oxPL (27). 
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 Non-radical reactive oxygen species like singlet oxygen or ozone can also contribute to PL oxida-
tion with generation of full-chain or fragmented oxPL.  
 PL having a polar head group with a modified amino-function (PE and PS) form a subclass named 
oxPL-Nmod. 
 
Shorthand notation for OxPL in general are presented in Table 4E. 
 
 
8. Sphingolipids (SP) 
 
Apart from sphingosine containing 18 C-atoms with two hydroxyl groups and one double bond, other sphin-
goid bases reveal prominent backbones as well, particularly in brain or non-mammalian specimens (28). 
Consequently, the abbreviation SPB is strongly recommended as shorthand notation for the general term 
“sphingoid bases”, Cer for ceramides, and SM for sphingomyelins (Table 5A). Tables 5B, C and D define 
in addition shorthand notation according to structural resolution of sphingolipids. The updated rules for 
shorthand notation are the following: 
 In case the long-chain base is not known, the sum composition of sphingoid base and fatty acid 
is shown as number of C-atoms:DBE;O-atoms, e.g. SPB 34:1;O2. 
 In ceramides the sphingoid backbone is annotated C-atoms:DBE;O-atoms separated by a slash 
from the number of C-atoms:DBE;O-atoms of the N-linked fatty acid, e.g. Cer 18:1;O2/16:0. 
 Double bond geometry and positions of hydroxyl groups (or other functional groups) are anno-
tated as described for fatty acyl-chains in Tab. 2B, e.g. Cer 18:1(4E);1OH,3OH/16:0. 
 When the number of hydroxyl groups cannot be determined, numbers of C-atoms and DBE are 
assigned under the assumption of the number of hydroxyl groups in the major sphingoid base for 
that organism (e.g. dihydroxy in mammals).  
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 For further characterization of N-linked fatty acids, rules as described in Section 4.2 apply. The 
position of a fatty acid esterified to an N-linked hydroxy-fatty acyl is shown in a separate pair of 
parentheses xO(FA C-atoms:DBE) with x denoting the position of hydroxyl group (∆ nomencla-
ture) in the N-linked fatty acids, e.g. Cer 18:1;O2/26:0;18O(FA 16:0).  
 Any modification linked to a sphingoid base-OH is written in front of (sub)class abbreviation 
with integrated position number in parenthesis at the end of abbreviation, e.g. FA 24:1-ACer(1) 
18:1;3OH/16:0 for an acylceramide, Gal-Cer(1) 18:0;3OH/16:0 for a galactosylceramide. 
 Consequently, in shorthand notation from “Structure defined level” onwards only unmodified 
OH-groups of the sphingoid base are annotated. 
 Shorthand notation for carbohydrate moieties is stated in Table 1C and examples are shown in 
Table 5D. 
 For annotation of the sugar moiety in complex glycosphingolipids we refer to current practice in 
glycan science (https://www.ncbi.nlm.nih.gov/glycans) (15). When the sequence of sugars com-
ponents is known, they are shown in this order separated by a hyphen. In case the sequence is 
unknown the components (followed by their number if more than one) are shown in alphabetic 
order in front of the respective lipid backbone. Annotation of the ceramide part follows the rules 
described above. 
 Sphingoid base phosphates with unknown phosphate position are represented by SPBP, e.g. 
SPBP 18:1;(OH)2. 
 Sphingoid base phosphates with known position of phosphate and of OH-positions is annotated 
by, e.g., SPBP(1) 18:1(4E);3OH.  
 Ceramide phosphates with unknown phosphate position are represented by CerP, e.g. CerP 
18:1;O2/16:0. 
 Ceramide phosphates with known position of phosphate and of OH-positions are annotated by, 
e.g., CerP(1) 18:1(4E);3OH.  
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 Ceramide phosphates with 1,3 cyclic phosphate and known OH-positions are annotated by, e.g., 
CerP(1,3) 18:1(4E). 
 
 
9. Sterols (ST) 
 
We use the term sterol to embrace all molecules based on the cyclopentanoperhydrophenanthrene skeleton. 
In the case of sterols the ring system does not add to the number of DBE. Endogenously biosynthesized 
mammalian sterols are derived from cholesterol or its precursors, yet plant and yeast sterols can also be a 
source via the food chain. The stereochemistry of the cholesterol molecule is maintained to a large extent 
by mammalian sterols, which all contain at least one hydroxyl or oxo group attached to carbon 3. High 
resolution MS with accurate mass may identify other functional groups as will MS/MS or MSn scans. Ste-
reochemistry can often be defined by comparing the chromatographic retention time to authentic standards 
and in some cases by MS/MS or MSn. The class abbreviations within category ST are shown in Table 6A. 
 
The following rules for shorthand nomenclature have been adopted in the examples given in Table 6B.  
 In shorthand notation the category abbreviation ST is used as class abbreviation. In some cases, 
other abbreviations e.g. FC, CE, BA, SE, SG and ASG can be used.  In all cases, class abbreviation 
is followed by number of carbon atoms:number of DB, and separated by semicolon is the number 
of oxygens, e.g. ST 27:1;O for cholesterol and lathosterol (also zymostenol), or ST 24:1;O5 for an 
oxidized sterol and for cholic acid and ursocholic acid. The latter is an important point: Some bile 
acids have an identical mass and molecular formula to oxidized sterols lacking a carboxylic acid 
group. This must be considered, when class abbreviation “BA” is used. 
 Shorthand notation of further functional groups are written, separated by a semicolon, after the 
number of oxygens, e.g. BA 24:1;O5;T for taurocholic acid (= common name, abbreviation TCA). 
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 Following the number of double bonds, proven position and stereochemistry is shown. R and S 
configurations are preferred for side-chain stereochemistry and are shown in square brackets. Alpha, 
written as a, and beta, written as b, are preferred for ring stereochemistry. Stereochemistry at C-5 
introduced by reduction of the Δ5 bond is indicated by 5aH or 5bH. Replacing the number of ox-
ygens, proven positions and stereochemistry of oxygen containing functional groups are shown. If 
such stereochemistry is known the common name of the compound can be used. 
 Alpha (below ring/plane), written as a, and beta (above ring/plane), written as b, are preferred for 
ring stereochemistry, e.g. 3aOH and 17bOH. 
 The side-chain at carbon-17 of the cyclopentanoperhydrophenanthrene skeleton always has beta-
stereochemistry (17b) and consequently is not presented in the shorthand annotation. 
 For structures fully proven or based on assumption by biological intelligence, such as e.g. choles-
terol, cholesteryl esters, sterol esters, bile acids, sterolglycosides, and acylsterolglycosides abbrevi-
ations FC, CE, SE, BA, SG and ASG, respectively, can be used as shown in Table 6A. CE is fol-
lowed by number of C-atoms:number of DBE of the fatty acid esterified to the hydroxyl group at 
position 3, e.g. CE 18:2 (Table 6B). Shorthand notation SE is used as above followed by slash (for 
monohydroxysterols) or underscore (for polyhydroxysterols) number of C-atoms:number DBE of 
the fatty acid esterified to the hydroxyl group (Table 6B).  
 MS/MS scans reveal the presence of conjugates: Taurine (T) and glycine (G) each are conjugated 
through an amide bond to the carboxylic acid group of bile acids, respective amide bonds with 
conjugates are designated in shorthand notation “COT” and “COG” (Table 6B); sulfuric acid (S) is 
conjugated to a hydroxyl group through an ester bond; glucuronic acid (GlcA), N-acetylglucosa-
mine (GlcNAc), and hexose (Hex) sugars are assumed to be linked to a hydroxyl group through an 
acetal linkage (Table 6B). 
 In the case full stereochemistry is known the common names as presented in Table 6B can be used. 
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10. Discussion and conclusions 
 
This publication updates both the classification and nomenclature (2, 3) and shorthand notation (4), and 
targets two goals. First, to emphasize and enable correct reporting of mass spectrometric data according to 
the resolving power of MS instrument platforms operating in high resolution (and often high throughput) 
mode. Second, to provide a comprehensible shorthand notation for the lipids commonly analyzed. Such 
common nomenclature is essential for standardized reporting of lipid species data and construction of data 
resources. Moreover, standardized data facilitate automated datamining and import into databases by script-
based algorithms with only minimal data curation. Related data repositories require a hierarchical concept 
mirroring the structural resolution provided by mass spectrometric analysis reflected in the presented short-
hand notation. To this end the LMSD database, respective MS search tool and, in particular shorthand no-
tations for all relevant lipids are now available on the LMSD detail view pages at “Species level” and “Mo-
lecular species level”, the latter embracing “Phosphate”-, “DB”-, and “sn-position level”. In a few instances, 
however, easy use of this shorthand notation by lipidomics experts has priority over its stringent use in a 
bioinformatics format. 
  
A standardized annotation for lipid species, as a common language, is a key component to promote and 
further advance this emerging omics discipline (29). Therefore, the Lipidomics Standards Initiative (LSI, 
https://lipidomics-standards-initiative.org/) has been recently introduced (13) pursuing development of 
guidelines and channeling community wide efforts in close collaborations with LIPID MAPS 
(https://www.lipidmaps.org/) as has been emphasized recently (30). In addition, alignment with other initi-
atives as for example adaptation of mzTab-M, a data format developed for metabolomics (31), to the pre-
sented nomenclature is possible. 
 
In summary, the shorthand nomenclature presented here is viewed as a standard in lipidomics that can be 
updated periodically.  
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Table 1A: Abbreviations of functional groups/side chains. Order of functional groups align with IUPAC 
hierarchy (14). 
Functional group/side chain Abbreviation 
ethyl branch Et 
methyl branch Me 
bromo Br 
chloro Cl 
fluoro F 
iodo I 
nitro NO2 
epoxy Ep 
peroxy OO 
methoxy OMe 
alkoxy (ether) oxy 
amino NH2 
hydroperoxy OOH 
sulfanyl SH 
hydroxy OH 
oxo (keto/aldehyde; depending on position) oxo 
cyano CN 
phosphate P 
sulfate S 
carboxylic acid COOH 
glycine G 
taurine T 
 
Table 1B: Abbreviations of cyclic structures. 
Cyclic structures Abbreviation 
cyclopropyl cy3 
cyclopropenyl cy3:1 
cyclobutyl cy4 
cyclopentyl cy5 
cyclohexyl cy6 
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Table 1C: Abbreviations of carbohydrate structures. Glycan annotation is based on IUPAC-approved ab-
breviations (https://www.ncbi.nlm.nih.gov/glycans/snfg.html) (15). 
Carbohydrate structures  Abbreviation 
Hexose Hex 
Galactose Gal 
Glucose Glc 
Mannose Man 
Neuraminic acid Neu 
N-acetyl hexosamine HexNAc 
N-acetyl galactosamine GalNAc 
N-acetyl glucosamine GlcNAc 
N-acetyl neuraminic acid NeuAc 
N-glycolylneuraminic acid NeuGc 
Keto-deoxy-glycero-galacto-nononic acid Kdn 
Glucuronic acid GlcA 
Xylose Xyl 
Fucose Fuc 
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Table 2A: Class abbreviations in Category FA. 
Common Name  Lipid Class - LIPID MAPS Abbreviation 
Fatty acids  Fatty Acids and Conjugates [FA01]  FA 
Fatty alcohols Fatty alcohols [FA05] FOH 
Fatty aldehydes Fatty aldehydes [FA06] FAL 
Acyl carnitines Fatty acyl carnitines [FA0707] CAR 
Acyl CoAs Fatty acyl CoAs [FA0705] CoA 
N-acyl amines  N-acyl amines [FA0802] NA 
N-acyl ethanolamines N-acyl ethanolamines (endocannabinoids) [FA0804] NAE 
N-acyl taurines  N-acyl amines [FA0802] NAT 
Wax esters Wax monoesters [FA0701] WE 
Wax diesters Wax diesters [FA0702] WD 
FA estolides FAHFA Wax monoesters [FA0701]  FA-EST 
 
 
Footnotes for Tables in Category FA: 
1. Uncharged molecular mass measured by low resolution mass spectrometry of corresponding m/z from carboxylate anion (electrospray ionization) or 
molecular ion species (radical cation by electron ionization). 
2. Annotation based on the assumption of a straight-chain fatty acyl plus functional groups based on exact mass measurements using a high-resolution mass 
spectrometer of fatty acyl indicating ion. 
3. Positions of double bonds determined by independent techniques such as ozonolysis (8) or photochemical derivatization (9). 
4. Shorthand notation applies only when exact location and nature of functional group(s) are determined by specific fragment ions obtained by derivatiza-
tion and GC/MS or specific product ions in a MS/MS experiment. 
5. Common shorthand accepted by IUPAC (23). 
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6. Validated assay is required to employ trivial names that engages appropriate internal standard, proper assessment of signal-to-noise, and a chromato-
graphic based separation of potential isomers (GC or HPLC). 
7. In shorthand notation for wax monoesters (WE), wax diesters (WD), and fatty amides (NA, NAE), alcohol and amine moieties precede the fatty acyl 
moiety. 
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Table 2B: Level-dependent shorthand notation for examples of fatty acids.  
Subclass Species level 1,2 DB-position level 3 Full structure level 4 Complete structure level (= Common name) 5,6 
Straight-Chain FA FA 12:0   Laurate 
 FA 14:0   Myristate 
 FA 16:0   Palmitate 
 FA 16:1 FA 16:1(9) FA 16:1(9Z) Palmitoleate 
 FA 18:0   Stearate 
 FA 18:1 FA 18:1(9) FA 18:1(9Z) Oleate 
 FA 18:1 FA 18:1(11) FA 18:1(11E) trans-Vaccenate 
 FA 18:2 FA 18:2(9,12) FA 18:2(9Z,12Z) Linoleate 
 FA 18:3 FA 18:3(9,12,15) FA 18:3(9Z,12Z,15Z) α-Linolenate 
 FA 18:3 FA 18:3(6,9,12) FA 18:3(6Z,9Z,12Z) γ-Linolenate 
 FA 18:4 FA 18:4(6,9,12,15) FA 18:4(6Z,9Z,12Z,15Z) Stearidonate 
 FA 20:0   Arachidate 
 FA 20:3 FA 20:3(8,11,14) FA 20:3(8Z,11Z,14Z) dihomo-γ-Linoleate 
 FA 20:3 FA 20:3(11,14,17) FA 20:3(11Z,14Z,17Z)  
 FA 20:3 FA 20:3(5,8,11) FA 20:3(5Z,8Z,11Z) Mead acid 
 FA 20:4 FA 20:4(5,8,11,14) FA 20:4(5Z,8Z,11Z,14Z) Arachidonate 
 FA 20:5 FA 20:5(5,8,11,14,17) FA 20:5(5Z,8Z,11Z,14Z,17Z) Eicosapentaenoate 
 FA 22:0   Behenate 
 FA 22:6 FA 22:6(4,7,10,13,16,19) FA 22:6(4Z,7Z,10Z,13Z,16Z,19Z) Docosahexaenoate 
 FA 24:0   Lignocerate 
 FA 24:1 FA 24:1(15) FA 24:1(15Z) Nervonate 
 FA 32:5 FA 32:5(14,17,20,23,26) FA 32:5(14Z,17Z,20Z,23Z,26Z) Dotriacontapentaenoic acid (FA 32:5n-6) 
 FA 34:5 FA 34:5(19,22,25,28,31) FA 34:5(19Z,22Z,25Z,28Z,31Z) Tetratriacontapentaenoic acid (FA 34:5n-3) 
 FA 36:6 FA 36:6(18,21,24,27,30,33) FA 36:6(18Z,21Z,24Z,27Z,30Z,33Z) Hexatriacontahexaenoic acid (FA 36:6n-3) 
Fatty acyl ester FA 19:0  FA 18:0;1OMe Methyl stearate  
Methyl branched FA 20:0  FA 16:0;3Me,7Me,11Me,15Me 5 FA 16:0;3Me,7Me[R],11Me[R],15Me (Phytanate) 
Hydroxy FA 18:0;O  FA 18:0;9OH FA 18:0;9OH[S] 
Oxo FA 11:1;O2  FA 11:0;9oxo FA 11:0;9oxo 
Cyclopropane FA 19:1  FA 19:0;[11-13cy3:0] 
Lactobacillic acid  
Cyclopropene FA 19:2  FA 19:0;[9-11cy3:1(9)] Sterculic acid  
Cyclopentene FA 18:3  FA 18:1(6Z);[14-18cy5:1(15)] 
Gorlic acid  
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Table 2C: Level-dependent shorthand notation for examples of fatty, aldehydes, esters and amides.  
Subclass 
Species level 
Molecular spe-
cies level 
DB-position level 3 Full structure level 4 
Complete structure level (= Common name) 5,6 
Fatty aldehyde FAL 9:1;O FAL 9:1;O FAL 9:1(2);OH FAL 9:1(2E);4OH 4-Hydroxynonenal 
Wax ester 7 WE 32:1 WE 14:0/18:1 WE 14:0/18:1(9) WE 14:0/18:1(9Z) WE 14:0/18:1(9Z) 
 
Alkyl acetates 7 WE 20:3 WE 18:3/2:0 WE 18:3(9,12,15)/2:0 WE 18:3(9Z,12Z,15Z)/2:0 WE 18:3(9Z,12Z,15Z)/2:0 
Wax diester 7 WD 42:0 WD 22:0/FA 
10:0_FA 10:0 
WD 22:0/FA 10:0_FA 10:0 WD 22:0;2O(FA 10:0),3O(FA 
10:0) 
WD 22:0;2O(FA 10:0[S]),3O(FA 10:0[R]) 
 
N-acyl amines 
(NA) 7 
NA 24:4 NA 4:0/20:4 NA 4:0/20:4(5,8,11,14) NA 4:0/20:4(5Z,8Z,11Z,14Z) NA 4:0/20:4(5Z,8Z,11Z,14Z) 
N-acyl ethanola-
mines (NAE) 7 
NAE 18:2 NAE 18:2 NAE 18:2(9,12) NAE 18:2(9Z,12Z) NAE 18:2(9Z,12Z) (Anandamide 18:2,n-6) 
 
Fatty acyl esto-
lides (FA-EST) 
FAHFA 36:1;O FAHFA 
18:1/18:0;O 
FAHFA 18:1(9)/18:0;O FAHFA 18:1(9Z)/9O(FA 18:0) FAHFA 18:1(9Z)/9O(FA 18:0[R]) 
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Table 2D: Shorthand notations for acyclic oxylipins at appropriate levels of annotation in lipidomic studies. 
Species level 1,2 DB-position level 3 Structure defined 
level 
Full structure level 4 Complete structure level (= Com-
mon name) 5,6 
FA 18:2;O FA 18:2(9,11);O FA 18:2;OH FA 18:2(9Z,11E);13OH 13R-HODE, 13S-HODE 
FA 20:4;O FA 20:4(6,8,11,14);O FA 20:4;OH FA 20:4(6E,8Z,11Z,14Z);5OH 5R-HETE, 5S-HETE 
FA 20:4;O FA 20:4(5,8,10,14);O FA 20:4;OH FA 20:4(5Z,8Z,10E,14Z);12OH 12R-HETE, 12S-HETE 
FA 20:4;O FA 20:4(5,8,11,13);O FA 20:4;OH FA 20:4 (5Z,8Z,11Z,13E);15OH 15R-HETE, 15S-HETE 
FA 20:4;O2 FA 20:4(6,8,10,14);O2 FA 20:4;(OH)2 FA 20:4(6Z,8E,10E,14Z);5OH,12OH LTB4 (5S,12R) 
 
FA 20:5;O3 FA 20:5(6,8,11,14,16);O3 FA 20:5;OOH;OH FA 20:5(6E,8Z,11Z,14Z,16E);5OOH;18OH 5S-Hp-18S-HEPE 
FA 20:5;O3 FA 20:5(6,8,10,14,16);O3 FA 20:5;(OH)3 FA 20:5(6Z,8E,10E,14Z,16E);5OH,12OH,18OH Resolvin E1 (5S,12R,18R) 
FA 22:6;O3 FA 22:6(4,8,10,12,14,19);O3 FA 22:6;(OH)3 FA 22:6(4Z,8E,10Z,12E,14E,19Z);7OH,16OH,17OH Resolvin D2 (7S,16R,17S) 
FA 22:6;O2 FA 22:6(4,8,10,12,16,19);O2 FA 22:6;(OH)2 FA 22:6(4Z,8E,10E,12E,16Z,19Z);7OH,14OH Maresin 1 (7R,14S) 
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Table 2E: Shorthand notations for cyclic oxylipins at appropriate levels of annotation in lipidomic studies. 
Species Level 1,2 Structure defined level Full structure level 4 Complete structure level (= Common name) 5,6 
FA 20:4;O3 FA 20:3;(OH)2;oxo FA 20:2(5Z,13E);[8-12cy5;11OH;9oxo];15OH PGE2 
 
FA 20:4;O3 FA 20:3;(OH)2;oxo FA 20:2(5Z,13E);[8-12cy5;9OH;11oxo];15OH PGD2 
FA 20:3;O3 FA 20:3;(OH)3 FA 20:2(5Z,13E);[8-12cy5;9OH,11OH];15OH PGF2α 
FA 20:3;O3 FA 20:2;(OH)2;oxo FA 20:1(13E);[8-12cy5;11OH;9oxo];15OH 8-iso-PGE1 
FA 20:3;O4 FA 20:2;(OH)3;oxo FA 20:1(13E);[8-12cy5;9OH,11OH];15OH;6oxo 6-oxo-PGF1α 
FA 20:3;O4 FA 20:3;(OH)3;oxy FA 20:2(5Z,13E);[8-13cy6;9OH,11OH);11oxy];15OH TXB2 
 
FA 22:5;O3 FA 22:5;(OH)3 FA 22:4(4Z,7Z,10Z,18E);[13-17cy5;14OH,16OH];20OH 20-F4-NeuroP 
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Table 2F: Parent polyunsaturated fatty acids and oxygenated product SPMs.   
Fatty acid Product class Complete structure level (= Common name) 
Arachidonic acid (AAn-6) Eicosanoid Lipoxin A4, Lipoxin B4 
Eicosapentaenoic acid (EPAn-3) Eicosanoid Resolvin E1, E2, E3 
Docosahexaenoic acid (DHAn-3) Docosanoid Resolvin D1, D2, D3, D4, D, D6 
Docosapentaenoic acid (DPAn-3) Docosanoid Resolvin T1, T2, T3, T4 
Docosahexaenoic acid (DHAn-3) Docosanoid PCTR1, PCTR2, PCTR3, Protectin D1/Neuroprotectin D1 
Docosahexaenoic acid (DHAn-3) Docosanoid MCTR1, 2 ,3, Maresins 1, 2 
Docosahexaenoic acid (DHAn-3) Docosanoid Protectin DX 
Dotriacontahexaenoic acid (FA 32:6n-3) Dotriacontanoid Elovanoid ELV-N32  
Tetratriacontahexaenoic acid (FA 34:6n-3) Tetratriacontanoid Elovanoid ELV-N34  
 
 
Table 2G: Parent polyunsaturated fatty acids and oxygenated product isoprostanoids.  
Fatty acid Product class Complete structure level (= Common name) 
α-Linoleic acid (ALA, n-3) Octodecanoid F1-PhytoP 
γ-Linolenic acid (GLA, n-6) Octodecanoid F1-PhytoPGLA 
Arachidonic acid (AA, n-6) Eicosanoid F2-IsoP 
Eicosapentaenoic acid (EPA, n-3) Eicosanoid F3-IsoP 
Adrenic acid (AdA, n-6) Docosanoid  F2-IsoPAdA 
Docosapentaenoic acid (DPA, n-6) Docosanoid F3-NeuroPDPAn-6 
Docosapentaenoic acid (DPA, n-3) Docosanoid F3-NeuroPDPAn-3 
Docosahexaenoic acid (DHA, n-3) Docosanoid F4-NeuroP 
 
 
 
FA 22:4(4Z,7Z,10Z,18E);[13-17cy5;14OH,16OH];20OH 
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Table 3A: Class abbreviations in Category GL. 
Common Name  Lipid Class – LIPID MAPS Abbreviation 
Monoacyl/alkylglycerides  (Monoglycerides) Monoradylglycerols [GL01]  MG  
Diacyl/alkylglycerides       (Diglycerides) Diradylglycerols [GL02]  DG  
Triacyl/alkylglycerides      (Triglycerides) Triradylglycerols [GL03]  TG  
Estolides Estolides [GL0305] TG-EST 
Sulfoquinovosylmonoacylglycerols;  Glycosylmonoacylglycerols [GL0401] SQMG 
Monogalactosylmonoacylglycerol Glycosylmonoacylglycerols [GL0401] MGMG 
Digalactosylmonoacylglycerol Glycosylmonoacylglycerols [GL0401] DGMG 
Sulfoquinovosyldiacylglycerols Glycosyldiacylglycerols [GL0501] SQDG 
Monogalactosyldiacylglycerol Glycosyldiacylglycerols [GL0501] MGDG 
Digalactosyldiacylglycerol Glycosyldiacylglycerols [GL0501] DGDG 
 
Footnotes for Tables in Category GL: 
1. Annotation based on exact mass measurements using a high-resolution mass spectrometer, which allows differentiation of isobaric acyl and alkyl species. 
2. Annotation using low resolution MS including the assumption of acyl chains only. 
3. Annotation requires MS/MS and detection of FA chain specific fragments. 
4. sn-Positions determined by specific analysis like differential mobility spectrometry (32) LC separation of isomeric species using silver ions (33). 
5. Only acyl-chain at sn-2-position is defined. 
6. DB-positons determined by independent techniques such as ozonolysis (8) or photochemical derivatization (9). 
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Table 3B: Examples for shorthand notation of glycerolipids. 
Bond type Species level 1 Molecular species level 3 sn-Position level 4 Full structure level 6 
Acyl  MG 18:0 MG 18:0  MG 0:0/18:0/0:0   
Alkyl  MG O-18:0 MG O-18:0  MG 0:0/O-18:0/0:0   
Diacyl  DG 34:1  DG 16:0_18:1  DG 16:0/18:1/0:0 DG 16:0/18:1(9Z)/0:0 
Acyl-alkyl DG O-34:1 DG O-16:0_18:1  DG O-16:0/18:1/0:0  DG O-16:0/18:1(9Z)/0:0  
Dialkyl  
DG dO-32:1 
DG 30:1 2 
DG O-16:0_O-16:1  DG O-16:0/O-16:1/0:0  DG O-16:0/O-16:1(9Z)/0:0  
Triacyl  TG 52:2  
TG 16:0_18:1_18:1 
TG 16:0_36:2 (only one acyl chain identified) 
TG 16:0/18:1/18:1 
TG 16:0_18:1(sn-2)_18:1 5 
TG 16:0/18:1(9Z)/18:1(11Z) 
Acyl-alkyl 
TG O-52:2 
TG 51:2 2 
TG O-16:0_18:1_18:1  TG O-16:0/18:1/18:1  TG O-16:0/18:1(9Z)/18:1(11Z) 
Acyl-dialkyl 
TG dO-52:2 
TG 50:2 2 
TG O-18:1_O-16:0_18:1 TG O-18:1/O-16:0/18:1 TG O-18:1(9Z)/O-16:0/18:1(9Z) 
Trialkyl 
TG tO-52:2 
TG 49:2 2 
TG O-18:1_O-16:0_O-18:1 TG O-18:1/O-16:0/O-18:1 TG O-18:1(9Z)/O-16:0/O-18:1(9Z) 
TG-Estolide TG 68:2;O2 TG 18:1_18:1_32:0;O2 TG 16:0;O(FA 16:0)/18:1/18:1 
TG 16:0;5O(FA 16:0)/18:1(9Z)/18:1(9Z) 
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Table 4A: Class abbreviations in Category GP. 
Common Name  Lipid Class - LIPID MAPS Abbreviation 
Bis[monoacylglycero]phosphates Monoacylglycerophosphomonoradylglycerols [GP0410] BMP 
Cardiolipins Glycerophosphoglycerophosphoglycerols [GP12] CL 
Phosphatidic acids Glycerophosphates [GP10] PA 
Phosphatidylcholines Glycerophosphocholines [GP01] PC 
Phosphatidylethanolamines Glycerophosphoethanolamines [GP02] PE 
Phosphatidylgylcerols Glycerophosphoglycerols [GP04] PG 
Phosphatidylgylcerolphosphates Glycerophosphoglycerophosphates [GP05] PGP 
Phosphatidylinositols Glycerophosphoinositols [GP06] PI 
Phosphatidylserines Glycerophosphoserines [GP03] PS 
Lysophospholipids  Prefix L 
Phosphatidylinositol-mannoside  PIM 
   
Subclasses phosphatidylinositol phosphates   
Phosphatidylinositol-monophosphates Glycerophosphoinositol monophosphates [GP07]  PIP  
Phosphatidylinositol-3-phosphates  Glycerophosphoinositol monophosphates [GP07]  PIP(3’) 
Phosphatidylinositol-4-phosphates  Glycerophosphoinositol monophosphates [GP07]  PIP(4’) 
Phosphatidylinositol-5-phosphates  Glycerophosphoinositol monophosphates [GP07]  PIP(5’) 
Phosphatidylinositol-bisphosphates  Glycerophosphoinositol bisphosphates [GP08]  PIP2  
Phosphatidylinositol-3,4-bisphosphates Glycerophosphoinositol bisphosphates [GP08]  PIP2(3’,4’) 
Phosphatidylinositol-3,5-bisphosphates Glycerophosphoinositol bisphosphates [GP08]  PIP2(3’,5’) 
Phosphatidylinositol-4,5-bisphosphates Glycerophosphoinositol bisphosphates [GP08]  PIP2(4’,5’) 
Phosphatidylinositol-trisphosphates  Glycerophosphoinositol trisphosphates [GP09]  PIP3  
   
N-modified phospholipids   
N-Alkyl PS  PS-N(Alk) 
N-Acyl PS  PS-N(FA) 
Phosphatidylserine-carboxyalkylpyrroles  PS-CAP 
Phosphatidylserine-malondialdehydes  PS-MDE 
N-Alkyl PE  PE-N(Alk) 
N-Acyl PE  PE-N(FA) 
Phosphatidylethanolamine-carboxyalkylpyrroles  PE-CAP 
Phosphatidylethanolamine-glucosides  PE-Glu 
Phosphatidylethanolamine-glucuronides  PE-GluA 
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Phosphatidylethanolamine-α-ketoglucoside  PE-GluK 
Phosphatidylethanolamine-carboxymethylates  PE-CM 
Phosphatidylethanolamine-carboxyethylates  PE-CE 
Phosphatidylethanolamine-formamides  PE-FA 
Phosphatidylethanolamine-carbamides  PE-CA 
Phosphatidyethanolamine- malondialdehydes  PE-MDE 
Phosphatidylethanolamine-hydroxynonenals  PE-HNE 
Phosphatidylethanolamine-isolevuglandins  PE-isoLG 
 
Footnotes for Tables in Category GP: 
1. Annotation based on exact mass measurements using a high-resolution mass spectrometer, which allows differentiation of isobaric acyl and alkyl species. 
2. Annotation using low resolution MS, e.g. QQQ and +PIS m/z 184 requires the assumption of even numbered carbon chains only. 
3. Annotation using low resolution MS, e.g. QQQ and +NL 141 requires the assumption of even numbered carbon chains only. 
4. Annotation requires MS/MS and detection of FA chain specific fragments. 
5. sn-Positions determined by specific MS analysis like differential mobility spectrometry (34). 
6. Identification of plasmalogens (alk-1-enyl bond) require specific MS analysis (35). 
7. Positions of double bonds determined by independent techniques such as ozonolysis (8) or photochemical derivatization (9).  
 
  
41 
Table 4B: Examples for shorthand notation of phospho- and lysophospholipids containing ester and/or ether bonds. 
Bond type Species level 1 Molecular species level 4 sn-Position level 5 Full structure level 7 
Diacyl  BMP 34:1  BMP 16:0_18:1 
BMP 16:0/0:0/18:1/0:0  
sn-2/sn-3/sn-2'/sn-3'  
BMP 16:0/0:0/18:1(9Z)/0:0  
sn-2/sn-3/sn-2'/sn-3'  
Tetraacyl CL 72:7 
CL 18:1_18:2_18:2_18:2 
CL 18:1_54:6 (only one acyl chain 
identified) 
CL 36:3_36:4 (known DG fragments) 
CL 18:1/18:2/18:2/18:2 
sn-1/sn-2/sn-1'/sn-2' 
CL 18:1(9Z)/18:2(9Z,12Z)/18:2(9Z,12Z)18:2(9Z,12Z) 
sn-1/sn-2/sn-1'/sn-2' 
Tetra-alkyl CL eO-80:0 CL O-20:0/O-20:0/O-20:0 /O-20:0 
CL O-20:0/O-20:0/O-
20:0/O-20:0 
CL O-16:0(3Me,7Me,11Me,15Me)/ 
O-16:0(3Me,7Me,11Me,15Me)/ 
O-16:0(3Me,7Me,11Me,15Me)/ 
O-16:0(3Me,7Me,11Me,15Me) 
Diacyl  PC 34:1 2 PC 16:0_18:1  PC 16:0/18:1  PC 16:0/18:1(9Z) 
Alkyl  PC O-34:1 2 PC O-16:0_18:1 PC O-16:0/18:1 PC O-16:0/18:1(9Z) 
Dialkyl  PC dO-34:1 PC O-16:0_O-18:1  PC O-16:0/O-18:1 PC O-16:0/O-18:1(9Z) 
Diacyl  PE 34:1 3 PE 16:0_18:1  PE 16:0/18:1  PE 16:0/18:1(9Z) 
Plasmalogen PE O-34:2 3  PE P-16:0/18:1 6 
PE P-16:0/18:1(9Z) 
Triacyl  LCL 54:5  LCL 18:1_18:2_18:2  LCL 18:1/18:2/18:2/0:0 LCL 18:1(9Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/0:0 
Monoacyl  LPC 16:0 2 LPC 16:0 LPC 16:0/0:0 LPC 16:0/0:0 
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Monoalkyl LPC O-16:0 2 LPC O-16:0 LPC O-16:0/0:0 LPC O-16:0/0:0 
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Table 4C: Examples for shorthand notation of phosphatidylinositol phosphates. 
Bond type Species level Phosphate position level Molecular species level sn-Position level Full structure level 
Diacyl PIP 36:1 PIP(3’) 36:1 PIP(3’) 16:0_18:1 PIP(3’) 16:0/18:1 
PIP(3’)] 16:0/18:1(9Z) 
 
Diacyl PIP2 38:4 PIP2(4’,5’) 38:4 PIP2(4’,5’) 18:0_20:4 PIP2(4’,5’) 18:0/20:4 PIP2(4’,5’) 18:0/20:4(4Z,8Z,11Z,14Z) 
 
Table 4D: Examples for shorthand notation of N-modified phospholipids. 
Oxidative modification Species level 1 Molecular species level 4 sn-Position level 5 Full structure level 
N-Alkyl PS-N(Alk) 40:3 PS-N(6:0)16:0_18:3 PS-N(6:0) 16:0/18:3 PS-N(6:0) 16:0/18:3(9Z,12Z,15Z) 
N-Acyl PE-N(FA) 54:5 PE-N(FA 18:1) 16:0_20:4 PE-N(FA 18:1) 16:0/20:4 
PE-N(FA 18:1(9Z)) 16:0/20:4(4Z,8Z,11Z,14Z) 
Hydroxynonenal adduct PE-HNE 36:4 PE-HNE 16:0_20:4 PE-HNE 16:0/20:4 PE-HNE 16:0/20:4(4Z,8Z,11Z,14Z) 
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Table 4E: Examples for shorthand notation of oxygenated phospholipids (OxPL). 
Oxidative modifi-
cation 
Species level 1 
Molecular species 
level 4 
sn-Position level 5 Structure defined level Full structure level 
Hydroxylation PC 36:4;O PC 16:0_20:4;O PC 16:0/20:4;O PC 16:0/20:4;OH PC 16:0/20:4(5Z,8Z,10E,14Z);12OH 
 PC 34:1;O2 PC 16:0_18:1;O2 PC 16:0/18:1;O2 PC 16:0/18:1;(OH)2 PC 16:0/18:1(9Z);12OH,13OH 
Epoxide PC 34:2;O PC 16:0_18:2;O PC 16:0/18:2;O PC 16:0/18:1;Ep PC 16:0/18:1(9Z);12Ep 
Hydroperoxide PC 34:2;O2 PC 16:0_18:2;O2 PC 16:0/18:2;O2 PC 16:0/18:2;OOH PC 16:0/18:2(9Z,11E);13OOH 
Peroxide PC 34:2;O2 PC 16:0_18:2;O2 PC 16:0/18:2;O2 PC 16:0/18:1;OO PC 16:0/18:1(9Z);12OO 
Aldehyde PC 21:1;O PC 16:0_5:1;O PC 16:0/5:1;O PC 16:0/5:0;oxo PC 16:0/5:0;5oxo 
Carboxylic acid  PC 25:1;O2 PC 16:0_9:1;O2 PC 16:0/9:1;O2 PC 16:0/9:0;COOH PC 16:0/9:0;8COOH 
Hydroxy-Alde-
hyde 
PC 26:3;O2 PC 18:1_8:2;O2 PC 18:1/8:2;O2 PC 18:1/8:1;OH;oxo PC 18:1(9Z)/8:1(6E);5OH;8oxo 
PC sn-2 position PC 36:4;O3 PC 16:0_20:4;O3 PC 16:0/20:4;O3 PC 16:0/20:2;[cy5;OH;oxo];OH 
PC 16:0/20:2(5Z,13E);[8-
12cy5;11OH;9oxo];15OH 
(common name 8-IsoPGE2-PC) 
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Table 5A: Class abbreviations in Category SP. 
Common Name  Lipid Class - LIPID MAPS Abbreviation 
Sphingoid bases  Sphingoid bases [SP01]  SPB  
Sphingoid base-phosphates  Sphingoid bases [SP0105]  SPBP 
Ceramides  Ceramides [SP02]  Cer  
Ceramide-phosphates Ceramide phosphates [SP0205] CerP 
Acyl Ceramides Acylceramides [SP0204] ACer 
Sphingomyelins  Phosphosphingolipids [SP03]  SM  
Hexosylceramides Neutral glycosphingolipids [SP05] HexCer 
Glucosylceramide Neutral glycosphingolipids [SP05] GlcCer 
Galactosylceramide Neutral glycosphingolipids [SP05] GalCer 
Dihexosylceramides Neutral glycosphingolipids [SP05] Hex2Cer 
Lactosylceramide Neutral glycosphingolipids [SP05] LacCer 
Sulfatides Sulfoglycosphingolipids (sulfatides) [SP0602] SHexCer 
Inositolphosphorylceramides Ceramide phosphoinositols [SP0303] IPC (PI-Cer) 
Ethanolaminephosphorylceramides Ceramide phosphoethanolamines [SP0302] EPC (PE-Cer)  
Glycosylinositolphosphorylceramides Ceramide phosphoinositols [SP0303] GIPC 
Mannosyl-inositolphosphoceramides Ceramide phosphoinositols [SP0303] MIPC 
Mannosyl-diinositolphosphoceramide Ceramide phosphoinositols [SP0303] M(IP)2C 
 
Footnotes for Tables in Category SP: 
1. Annotation based on exact mass measurements using a high-resolution mass spectrometer. 
2. Annotation using low resolution MS QQQ and a PIS m/z 184 requires the assumption of a sphingoid base with two hydroxyl groups. 
3. Annotation requires MS/MS enabling detection of sphingoid base and/or N-linked FA. 
4. Annotation with structural characterization of O-acyl in N-linked acyl chain. 
5. Annotation without structural differentiation of N-linked acyl chain. 
6. Positions of functional groups and double bonds determined by independent techniques such as chromatographic resolution, ozonolysis (8) or photo-
chemical derivatization (9). 
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7.  Separation of isomeric hexosylceramide by HILIC (36). 
8. Annotation requires separation of stereoisomers at glycosidic linkage (alpha/beta) 
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Table 5B: Examples for shorthand notation of sphingolipids with a free amino group. 
Sphingoid base Species level 1 Structure defined level Full structure level 6 
Sphingosine  SPB 18:1;O2 SPB 18:1;(OH)2 
SPB 18:1(4E);1OH,3OH 
 
3-Keto-sphinganine SPB 18:1;O2 SPB 18:0;OH;oxo SPB 18:0;1OH;3oxo 
Sphinganine  SPB 18:0;O2 SPB 18:0;(OH)2 SPB 18:0;1OH,3OH 
Sphingadiene  SPB 18:2;O2 SPB 18:2;(OH)2 SPB 18:2(4E,14Z);1OH,3OH  
Phytosphingosine SPB 18:0;O3 SPB 18:0;(OH)3 SPB 18:0;1OH,3OH,4OH 
C20-Sphingosine SPB 20:1;O2 SPB 20:1;(OH)2 SPB 20:1(4E);1OH,3OH 
Sphingosine-1-phosphate  SPBP 18:1;O2 SPBP 18:1;OH 
SPBP(1) 18:1(4E);3OH 
 
Sphinganine-1-phosphate  SPBP 18:0;O2  SPBP 18:0;OH SPBP(1) 18:0;3OH 
1-Deoxymethyl-sphinganine SPB 17:0;O SPB 17:0;OH SPB 17:0;2OH 
1-Deoxy-sphinganine SPB 18:0;O SPB 18:0;OH SPB 18:0;3OH 
Lysoinositolphosphorylcer-
amides 
LIPC 18:0;O3 LIPC 18:0;(OH)2 
LIPC(1) 18:0;3OH,4OH 
 
Lysosphingomyelin  LSM 18:1;O2 LSM 18:1;OH LSM(1) 18:1(4E);3OH 
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Table 5C: Examples for shorthand notation of sphingolipids containing an amide bound fatty acid. 
Phyla Species level 1 Molecular species level 3 Full structure level 6 
Mammalian  Cer 34:1;O2 Cer 18:1;O2/16:0 
Cer 18:1(4E);1OH,3OH/16:0  
 
Mammalian Cer 34:0;O2 Cer 18:0;O2/16:0 Cer 18:0;1OH,3OH/16:0 
Mammalian ACer 58:1;O2 FA 24:1-ACer 18:1;O2/16:0 FA 24:1-ACer(1) 18:1(4E);3OH/16:0 
Mammalian CerP 34:1;O2 CerP 18:1;O2/16:0 CerP(1) 18:1(4E);3OH/16:0 
Mammalian 
SM 36:2;O2 2 SM 18:2;O2/18:0 
SM(1) 18:2(4E,14Z);3OH/18:0 
 
Mammalian SM 44:2;O2 2 SM 20:1;O2/24:1 SM(1) 20:1(4E);3OH/24:1(15Z)  
Mammalian 
Cer 62:3;O4 
Cer 18:1;O2/26:0;O(FA 18:1) 4 
Cer 18:1;O2/44:2;O2 5 
Cer 18:1(4E);1OH,3OH/26:0;26O(FA 18:1(9Z)) 
Plant  
IPC 42:1;O4 IPC 18:1;O3/24:0;O 
IPC(1) 18:1(8E);3OH,4OH/24:0;2OH 
 
Yeast  Cer 44:0;O5 Cer 18:0;3O/26:0;O2 Cer 18:0;1OH,3OH,4OH/26:0;2OH,3OH 
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Table 5D: Examples for shorthand notation of glycosphingolipids containing an amide bound fatty acid. 
Phyla Species level 1 Molecular species level 3 Full structure level 6 
Mammalian 
Hex-Cer 34:1;O2 
Hex-Cer 18:1;O2/16:0 
Glc-Cer 18:1;O2/16:0 7 
Glc-Cer(1) 18:1(4E);3OH/16:0 (see also Figure 1) 
Mammalian 
Hex-Cer 34:0;O2 
Hex-Cer 18:0;O2/16:0 
Gal-Cer 18:0;O2/16:0 7 
Gal-Cer(1) 18:0;3OH/16:0  
Mammalian 
Hex2Cer 34:1;O2 Hex2Cer 18:1;O2/16:0 
Lac-Cer(1) 18:1(4E);3OH/16:0 8 
Gal-Glc-Cer(1) 18:1(4E);3OH/16:0 
Mammalian Hex3Cer 42:1;O2 Hex3Cer 18:1;O2/24:0 Gal-Gal-Glc-Cer(1) 18:1(4E);3OH /24:0 (Gb3) 
Mammalian NeuAcHex2Cer 42:1;O2 NeuAcHex2Cer 18:1;O2/24:0 NeuAc-Gal-Glc-Cer(1) 18:1(4E);3OH /24:0 (GM3) 
Mammalian NeuAc2Hex2Cer 42:1;O2 NeuAc2Hex2Cer 18:1;O2/24:0 NeuAc-NeuAc-Gal-Glc-Cer(1) 18:1(4E);3OH /24:0 (GD3) 
Mammalian 
SHex-Cer 34:1;O2 SHex-Cer 18:1;O2/16:0 
S(3’)Hex-Cer(1) 18:1(4E);3OH/16:0 
S(3’)Gal-Cer(1) 18:1(4E);3OH/16:0 8 
 
 
Mammalian 
SHexHexNAcHex3Cer 34:1;O2 SHexHexNAcHex3Cer 18:1;O2/16:0 
S(3’)Hex-HexNac-Hex-Hex-Hex-Cer(1) 18:1(4E);3OH/16:0 
S(3’)Gal-GalNAc-Gal-Gal-Glc-Cer(1) 18:1(4E);3OH/16:0 8 
(Globopentaosylceramide sulfate) 
Plant  HexA-IPC 42:1;O4 HexA-IPC 18:1;O3/24:0;O GlcA-IPC(1) 18:1(8E);3OH,4OH/24:0;2OH 
Plant  HexHexA-IPC 42:1;O4 Hex-HexA-IPC 18:1;O3/24:0;O Glc-GlcA-IPC(1) 18:1(8E);3OH,4OH/24:0;2OH 
Plant  HexAHexNAc-IPC 42:1;O4 HexNAc-HexA-IPC 18:1;O3/24:0;O GlcNAc-GlcA-IPC(1) 18:1(8E);3OH,4OH/24:0;2OH 
Plant  
HexHexAHexNAc-IPC 42:1;O4 
Hex-HexNAc-HexA-IPC 
18:1;O3/24:0;O Glc-GlcNAc-GlcA-IPC(1) 18:1(8E);3OH,4OH/24:0;2OH 
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Yeast 
MIPC 44:0;O4 MIPC 18:0;O3/26:0;O 
MIPC(1) 18:0;3OH,4OH/26:0;2OH 
 
 
 
 
Yeast M(IP)2C 46:0;O4 M(IP)2C 20:0;O3/26:0;O M(IP)2C(1) 20:0;3OH,4OH/26:0;2OH 
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Table 6A: Class abbreviations in Category ST. 
Common Name  Lipid Class - LIPID MAPS Abbreviation 
Sterols Sterols [ST01] ST 
Sterol esters Sterol esters [ST0102] SE 
Bile acids Bile acids and derivatives [ST04] BA 
Free cholesterol = cholesterol  FC  
Cholesterol ester Cholesterol esters [ST0102] CE 
Sterolglycosides Sterolglycosides  SG 
Acylsterolglycosides Monoradylglycosterols  ASG 
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Table 6B: Examples of shorthand notation for sterols. 
Lipid class Species level  Full structure level Complete structure level (= Common Name) 
ST (FC) ST 27:1;O ST 27:1(5Z);3bOH = FC Cholesterol  
ST ST 27:1;O ST 27:1(7);5aH;3bOH Lathosterol  
ST ST 28:3;O ST 28:3(5Z,7Z,22E);24Me[R];3bOH Ergosterol  
ST ST 27:2;O3 ST 27:1(5Z);3bOH;26COOH[25R] 3β-Hydroxycholest-5-en-(25R)26-oic acid 
SE SE 27:1/16:0 CE 16:0 Cholesteryl palmitate 
SE SE 27:1/18:2 CE 18:2(9Z,12Z) Cholesteryl linoleate 
SE SE 27:2/18:1 SE 27:2(8E,24);5aH/18:1(9Z) Zymosteryl oleate 
ST ST 21:3;O2 ST 21:1(4Z);3oxo,20oxo Progesterone 
ST ST 19:2;O2 ST 19:1(4Z);17bOH;3oxo Testosterone 
ST ST 19:2;O2 ST 19:1(5Z);3bOH;17oxo Dehydroepiandrosterone  
ST ST 18:3;O2 ST 18:3(1,3,5);3OH,17bOH 17β-Estradiol  
ST ST 19:2;O2;S ST 19:1(5Z);3bS;17oxo 
Dehydroepiandrosterone sulfate 
BA ST 24:1;O5 BA 24:0;5bH;3aOH,7aOH,12aOH;24COOH Cholic acid (CA) 
BA ST 24:1;O3 BA 24:0;5bH;3aOH;24COOH Lithocholic acid (LCA) 
BA BA 24:1;O5;T BA 24:0;5bH;3aOH,7aOH,12aOH;24COT Taurocholic acid (TCA) 
BA BA 24:1;O4;G BA 24:0;5bH;3aOH,7aOH;24COG Glycochenodeoxycholic acid (GCDCA) 
BA ST 24:1;O4;HexNAc BA 24:0;5bH;3aOH,7bOGlcNAc;24COOH Ursodeoxycholic acid 7β-N-acetylglucosaminide (UDCA-GlcNac) 
SG SG 27:1;O;Hex SG 27:1(5Z);3bOGlc Cholesterol glucoside  
ASG ASG 29:2;O;Glc;FA20:3 ASG 29:2(5Z,22E);24Et[S];3bOGlc;6O(FA 20:3) 
20:3(11Z,14Z,17Z)-Glc-Stigmasterol 
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Figure 1 Hierarchical scheme for the analysis of glucosylceramide.  
“Analysis” presents MS-data and “Annotation” the respective hierarchical levels with corresponding 
shorthand annotation. The chemical structure illustrates the Complete Structure level, numbers along 
the sphingoid base indicate conventional numbering of carbons therein.  
 
 
